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BACKGROUND: Functional capacity assessment may be 
a useful tool to stratify patients according to risk of coronary 
artery disease (CAD). The Duke Activity Status Index (DASI) 
is a functional assessment based on activities of daily living 
and cardiovascular fitness, assessed using a self-administered 
questionnaire. 
MATERIAL AND METHODS: We assessed the relationship 
between established clinical risk factors for CAD and the DASI 
with results of myocardial perfusion scintigraphy (MPS). The 
MPS results used in the analysis were the presence of reversible 
ischaemia and the resting left ventricular ejection fraction (LVEF).
A DASI self-administered questionnaire was completed by 117 
consecutive participants, and a patient history was taken to 
ascertain established risk factors. All participants underwent 
a stress test, and myocardial perfusion scintigraphy was 
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performed. Statistical analysis consisted of logistic and linear 
regression using a statistical software package.
RESULTS: The DASI was the only factor that correlated signifi-
cantly with reversible ischaemia on MPS. None of the previously 
established risk factors had a significant association with revers-
ible ischaemia within the model. Our study found a potential 
relationship between the DASI score and the left ventricular ejec-
tion fraction (LVEF) although this was not statistically significant.
CONCLUSIONS: Our study findings suggest that the DASI may 
represent a powerful tool for risk stratification prior to investiga-
tion of CAD. A further study with a larger sample size will be 
required to investigate the predictive value of the DASI and the 
association with LVEF.
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Introduction
Myocardial perfusion scintigraphy (MPS) is a widely utilised 
method of non-invasive cardiac imaging and is central to the 
diagnosis and management of coronary artery disease (CAD). 
The test detects the effect of fixed or dynamic flow limiting coro-
nary stenosis. Gating also allows assessment of left ventricular 
ejection fraction (LEVF), wall motion, and wall thickening. Myo-
cardial perfusion imaging is a particularly useful screening test 
for exercise intolerant patients and those who have inconclusive 
stress echocardiography. The test is an established and valuable 
screening test for CAD [1]. The current American guidelines state 
that the undertaking of a stress imaging test must be preceded by 
a pre-test likelihood assessment of CAD [2]. This is in keeping with 
the UK National Institute of Health and Clinical Effectiveness (NICE) 
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guidelines, which recommend pre-test likelihood of CAD should 
be based on age, gender, ethnicity, family history, associated 
co-morbidities, clinical presentation, physical examination, and re-
sults from other investigations [3]. National guidelines recommend 
MPS for the diagnosis of CAD in the following circumstances: 
— as an initial tool for patients with suspected CAD in whom 
stress electrocardiography poses problems (e.g. females, left 
bundle branch block, mobility problems);
— for investigation of suspected CAD in patients with a lower 
likelihood of CAD;
— as part of the investigational strategy for established CAD in 
patients who remain symptomatic. Evidence suggests that 
major risk factors for CAD include “typical” chest pain, age, 
and male sex whereas factors such as smoking and hyperli-
pidaemia have been evaluated as minor factors [4–6]. 
Over the last decade the effectiveness of cardiovascular thera-
pies and outcomes have been evaluated using health-related qual-
ity tools and functional capacity assessments.  A well-recognised 
functional capacity tool is the Duke Activity Status Index (DASI), 
which is a self-administered questionnaire that measures the 
ability to perform a set of 12 common activities of daily living. 
It has been validated against the “gold standard” of functional 
capacity measurement: peak oxygen intake during exercise [7]. 
The non-weighted DASI is scored as 1 point for each activity 
whereas the weighted score is calculated by adding together 
the ‘MET units’ for each activity. MET units are a measure of the 
metabolic cost of the activity and were derived in the original study 
by Hlatky and colleagues (Table 1) [7]. 
DASI has been used to monitor progress in patients with 
coronary artery disease, has demonstrated prognostic value in 
patients with chronic heart failure, and can be used to identify those 
with reduced long-term survival following cardiac surgery [8–10]. 
The DASI has not as yet been investigated as a predictor of abnor-
mal MPS. This study investigates the relationship between the DASI 
and established pre-test risk factors with the presence of reversible 
ischaemia and LVEF on myocardial perfusion scintigraphy. 
Material and methods
Ethical approval was granted prior to the undertaking of 
this study. Prospectively, 117 consecutive eligible patients were 
recruited over a six-month period. All patients referred for investi-
gation of chest pain according to the original request form were 
assessed for eligibility in the study. Exclusion criteria included 
inability to understand the questionnaire or give consent, incom-
plete forms, and immobility. All patients had their medical history 
taken by a doctor to establish risk factors prior to the test. Demo-
graphic data was also noted. Patients were requested to complete 
a self-administered questionnaire between their pharmacological 
stress and image acquisition. The questionnaire consisted of 
the 12-point abbreviated DASI and was scored as non-weighted 
and weighted results based on the original study by Hlatky et al. 
(Table 1).  
The sample included 65 men (56%) and 52 women (44%). The 
mean age was 65 and the age range was 32 to 87. The risk fac-
tors that were assessed in the medical history and their prevalence 
among the sample population are displayed in Table 2. A positive 
family history was defined as one or more first degree relatives with 
coronary artery disease and obesity as a body mass index (BMI) 
greater than 30. 
All patients were stressed with Adenosine or Dobutamine ac-
cording to standard protocols of myocardial perfusion scintigraphy 
using a standard 2 day protocol. Stress and rest imaging were 
performed at least 48 hours apart using 500 MBq 99mTc tetrofos-
min. The imaging was performed on a dedicated cardiac gamma 
Table 1. The Duke Activity Status Index [7]
Activity Weight (MET units)
Take care of yourself, that is, eating, dressing, bathing and using the toilet? 2.75
Walk indoors such as around your house? 1.75
Walk a block on level ground? 2.75
Climb a flight of stairs or walk up a hill? 5.50
Run a short distance? 8.0
Do light housework like dusting or washing dishes? 2.7
Do moderate housework like vacuuming, sweeping floors, carrying in groceries? 3.5
Do heavy housework like scrubbing floors, or lifting or moving heavy furniture? 8.0
Do gardening including such things as raking leaves, weeding, or pushing a lawn mower? 4.5
Have sexual relations? 5.25
Participate in moderate recreational activities, like golf, bowling, dancing, or throwing a ball? 6.0
Participate in strenuous sports like swimming, football, basketball, or skiing? 7.5











> 3 risk factors c 32
a PTCA — previous percutaneous transluminal coronary angioplasty;  bCABG — previous 
coronary artery bypass graft; c >3 risk factors: includes those listed in this table only
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camera (Siemens C-Cam, Erlangen, Germany). A rest-gated 
acquisition was obtained. Images were reconstructed iteratively 
using a count optimised smoothing filter. Attenuation correction 
was not applied. For the purposes of analysis we recorded the left 
ventricular ejection fraction and the presence/absence of revers-
ible ischaemia. Ischaemia was defined as a reduction of more 
than 50% of the maximum activity seen in the stress image which 
showed greater than 75% of the maximum activity in the rest image 
and covered > 10% of the myocardium. These outcomes were 
subsequently correlated with functional capacity assessed from 
the DASI (weighted and non-weighted scores), demographics, 
and established risk factors. Individual factors and their ability to 
predict changes on the myocardial scintigraphy were tested using 
statistical analysis performed using XLSTAT 2009 version 2.03. 
Statistical significance is regarded as p < 0.05.
Results
All questions were answered on the DASI questionnaire except 
the question on sexual relations, which was left blank by 17 (14.5%) 
participants. The left ventricular ejection fraction was reported on 
92 MPS results as it was not possible to gate the study in 25 pa-
tients. Of the 117 participants 30.8% had demonstrable evidence 
of reversible ischaemia on MPS. 47.2% of all participants with 
reversible ischaemia had 3 or more risk factors, whereas 38.3% 
of all patients without evidence of reversible ischaemia had 3 or 
more risk factors.  
Univariate and multivariate logistic regression was performed. 
The multivariate analysis consisted of 92 cases since those with-
out a resting LEVF result were excluded (these were patients in 
which gating was not possible due to arrhythmia). Univariate and 
multivariate analysis revealed that only the DASI (both weighted 
and non-weighted) has a significant association with reversible 
ischaemia (Table 3). 
The multivariate analysis revealed the following when modelled 
with the presence/absence of reversible ischaemia: non-weighted 
DASI odds ratio 0.325 (95% CI: 0.13–0.82) p = 0.017, weighted 
DASI odds ratio 0.838 (95% CI: 0.71–0.99) p = 0.038. The multiva- 
riate model overall did not achieve statistical significance accord-
ing to the Fischer’s F statistic; however, the DASI scores alone 
were significant predictors of reversible ischaemia. 
The ROC (receiver operating characteristic) curve for the 
non-weighted DASI (univariate logistic regression) demonstrated 
that the DASI score has a statistically significant relationship with 
reversible ischaemia; however, this does not have a high sensi-
tivity or specificity (Figure 1). The ROC curve for the weighted 
DASI is similar (area under curve = 0.661, p < 0.001).  Each of 
the remaining risk factors did not have a statistically significant 
independent relationship to reversible ischaemia in univariate or 
multivariate analyses.
As 14.5% of the participants did not respond to a question on 
sexual relations in the questionnaire, a second analysis was per-
formed in which this particular question was removed to produce 
“adjusted” DASI scores. Therefore, the adjusted non-weighted 
Table 3. Univariate logistic regression 
Variable Odds Ratio (CI 95%) P value
DASI score (non-weighted) 0.820 (0.72–0.93) 0.002*
DASI score (weighted) 0.967 (0.95–0.99) 0.006*
LVEF  0.990 (0.96–1.03) 0.591
Age 1.026 (0.99–1.06) 0.135
Male sex 0.723 (0.33–1.59) 0.432
Hypercholesterolaemia 0.957 (0.40–2.22) 0.92
Hypertension 1.20 (0.52–2.79) 0.67
Known CAD 1.060 (0.72–3.57) 0.252
Smoking history 1.425 (0.62–3.28) 0.405
Family history 0.952 (0.39–2.35) 0.916
Diabetes 1.255 (0.51–3.06) 0.618
Obesity 1.789 (0.73–4.34) 0.20
PTCA 0.772 (0.26–2.33) 0.646
CABG 2.016 (0.57–7.10) 0.275
> 3 risk factors 1.835 (0.76–4.45) 0.179
*The DASI is statistically significant on the basis of the probability of c2 test in logistic regression, and the validity of the overall model is confirmed by the Fischer’s F Test, which 
showed the following when modelled for reversible ischaemia:  non-weighted DASI: p = 0.001, weighted DASI: p = 0.004
Figure 1. The area under the curve above is 0.672. The ROC curve 
corresponds to the logistic regression statistics for the non-weighted 
DASI in Table 3. 
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score was out of a maximum possible score of 11 and the ad-
justed weighted DASI assessed as a maximum score of 52.95. 
In this second analysis, the odds ratio for the adjusted weighted 
DASI score and reversible ischaemia was 0.981 (CI: 0.968–0.994), 
p = 0.006, Fischer’s F test 0.004, area under ROC = 0.662, and 
the odds ratio for the adjusted non-weighted DASI score and re-
versible ischaemia was 0.976 (95% CI: 0.962–0.991), p = 0.002, 
Fishers F Test p = 0.001, area under ROC = 0.653. 
The relationship between the non-weighted DASI score 
was further analysed with respect to the presence of reversible 
ischaemia (Table 4, Figure 2). This demonstrates the inverse trend 
between an increasing DASI score and the rates of demonstrable 
reversible ischaemia. It reveals, however, that 20% of those with 
a DASI score between 0 and 2 inclusive did not have reversible 
ischaemia and 19.4% of those with DASI scores or 11 or 12 did. 
Through linear regression, the left ventricular fraction was cor-
related against the weighted DASI (Spearman’s rho = –0.1855; 
95% CI: –0.3773–0.02167, p = 0.0705) and non-weighted DASI 
scores (Spearman’s rho = –0.15; 95% CI: –0.3773–0.02167, 
p = 0.14). Although no statistically significant results were found, 
left ventricular ejection fraction is close to statistical significance 
when correlated against the weighted DASI score. 
Discussion 
Investigation and treatment of CAD has evolved rapidly over 
the past decade. The overall goal of MPS is to increase detection of 
patients in whom there may be a significant survival advantage of 
coronary intervention, and to identify those who do not have CAD. 
Broad clinical guidelines have been developed for the investiga-
tive pathway for patients with suspected coronary artery disease, 
which state that a stress imaging study must be preceded by 
a pre-test likelihood of CAD [2–3, 11]. Consensus regarding the 
quantification of risk, however, is lacking and must be determined 
by the clinician based on a Bayesian analysis of risk factors, clini-
cal history, and non-invasive tests such as echocardiography. It 
is suggested that patients with high risk of CAD may be appropriate 
referrals for angiography where benefits outweigh the risks of the 
procedure. In contrast, patients of intermediate and low risk are 
appropriate referrals for MPS. MPS has a good safety profile and 
there is evidence to demonstrate its strength in correctly identify-
ing those at very low risk of cardiac events [12, 13]. Furthermore, 
MPS has also been correlated with angiographic findings, which 
demonstrate increasing likelihood of benefit from revascularisation 
with greater perfusion defects on MPS [14]. 
Nelson and colleagues studied associations between the 
DASI and clinical risk factors to angiographic evidence of CAD 
[15]. The authors validated the DASI as a functional outcome 
measure and demonstrated significant measurable differences in 
DASI scores between groups of patients with varying severity of 
CAD [15]. Furthermore, in their study, functional capacity was not 
associated with any combination of clinical factors (e.g. diabetes, 
smoking, and angina) [15]. These findings are in keeping with our 
study, which also found that, although not highly sensitive or spe-
cific, the DASI is the only pre-test variable which has a statistically 
significant association with reversible ischaemia. It is thus a more 
powerful pre-test predictor of reversible ischaemia on MPS than 
any of the established risk factors included in the study. Further 
investigation is required to assess the positive predictive value 
of this test and the realistic trade offs between sensitivity and 
specificity. The DASI has potential for use in cases where a low 
DASI score (i.e. 0–2) indicates patients at high risk of reversible 
ischaemia who warrant expedited investigation and treatment. The 
DASI is a short, 12-point questionnaire, which is easy to administer 
making it a feasible and low-cost tool for use in a clinical setting. 
The DASI has been used as an estimate of functional capac-
ity in patients with heart failure and can also provide prognostic 
information in patients with chronic heart failure [10]. Nelson 
and colleagues, however, did not find that the ejection fraction 
was predictive of functional capacity, and this has also been 
observed by other investigators [15–17]. Similarly, our study did 
not confirm a significant relationship; however, the result for the 
weighted DASI score was close to statistical significance, indicat-
ing that a relationship may exist. Further investigation with a larger 
Table 4. Characteristics of participants according to DASI score
DASI score Reversible ischaemia (n) N Males 3 or more risk factors (n)
0 to 2 80% (8) 10 60% (2) 20%
3 or 4 35% (6) 17 29.40% (9) 52.9%
5 or 6 28.60% (6) 21 52.40% (14) 67%
7 or 8 32% (8) 25 52% (7) 28%
9 or 10 15.40% (2) 13 76.90% (5) 38.5%
11 or 12 19.40% (6) 31 64.50% (15) 48.4%
Figure 2. The relationship of DASI score to incidence of ischaemia as 
seen on MPS.
63www.nmr.viamedica.pl
Marc J. George et al. Value of DASI in predicting reversible ischaemia in MPS
Original
sample size will be required to determine the precise value of the 
DASI in this context.
There were poor responses rates for a question on sexual 
relations in the DASI questionnaire (14.5% of participants left 
this question blank), which therefore had an effect on the over-
all DASI scores. To ensure validity the scores for the weighted 
and non-weighted DASI were adjusted for this omission and 
re-analysed. The adjusted models have no change in the p value 
or Fischer’s F test. This demonstrates that our results were not 
significantly affected by this factor. We must also take into ac-
count that bias may be introduced through patient responses by 
the education background and health awareness of participants. 
Definitions of chest pain were taken from the referral forms from 
the requesting clinician, which may also represent a potential 
source of bias. The investigators of the CASS study demonstrated 
high prevalence of coronary and multi-vessel disease in specific 
groups according to gender and definitions of chest pain [4].
Conclusions
The DASI is potentially a powerful tool to establish the likeli-
hood of reversible ischaemia on MPS in patients with chest pain. 
This study demonstrates that the DASI is more reliable than 
previously established pre-test risk factors in predicting CAD in 
this cohort. It highlights that functional capacity in terms of car-
diovascular ability is a valid measure of CAD risk. An important 
use of the DASI may be to identify patients with a low score in 
whom expedited investigation and treatment may confer a survival 
benefit. Further research in a bigger patient group is required to 
investigate the strength of the association between resting LVEF 
and weighted DASI score. 
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